“We Can Do This!”: The Role of Physical Activity in What Comes Next for Dementia

Author:

Russell Christopher1ORCID

Affiliation:

1. Association for Dementia Studies, University of Worcester, Henwick Grove, Worcester WR2 6AJ, UK

Abstract

There is increasing interest in physical activity as a response to the harm caused by dementia. The focus has been upon interventions to prevent or delay symptoms or to support people living with the condition to reminisce. Whilst this is welcome, there are other features inherent to physical activity that remain unrecognised or underutilised and, consequently, its full potential for good is unrealised. Most prominent is the ability physical activity has to enable participants to claim and sustain a place in the world through what they do, crucial to a context where the impact of dementia tends to annihilate this for those living with the condition. The article addresses this gap. In doing so, it presents key findings. These include (1) highlighting the fundamental importance of features such as person-centred care, human rights and social citizenship to enabling people with dementia to live lives of quality and (2) identifying synergies with these features and what physical activity can offer; for example, emphasising the value of bringing these together to illustrate how physical activity can contribute to enabling people with dementia to live lives characterised by quality, and the maintenance of their place in the world. The article concludes by suggesting what must come next to ensure physical activity can play the fullest role possible.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference47 articles.

1. Dementia: Definitions and types;Dening;Nurs. Stand.,2015

2. Alzheimer’s Disease International (2023, April 12). World Alzheimer Report 2014, Dementia and Risk Reduction. Available online: https://www.alz.co.uk/research/WorldAlzheimerReport2014.pdf.

3. Alzheimer Europe (2021). Behind the headlines: FDA approval of aducanumab marks a watershed moment for the Alzheimer’s disease community. Dement. Eur., 37, 36–37.

4. New Scientist (2023, April 17). Alzheimer’s Drug Results are Promising—But not a Major Breakthrough. Available online: https://www.newscientist.com/article/2340082-alzheimers-drug-results-are-promising-but-not-a-major-breakthrough/.

5. British Broadcasting Corporation (2023, May 03). New Alzheimer’s drug Slows Disease by a Third. Available online: https://www.bbc.co.uk/news/health-65471914.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3